Larkspur Health Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LSPR and buy or sell other stocks, ETFs, and their options commission-free!About LSPR
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases.
CEOStephen C. Glover
CEOStephen C. Glover
Employees7
Employees7
HeadquartersWeston, Florida
HeadquartersWeston, Florida
Founded2014
Founded2014
Employees7
Employees7
LSPR Key Statistics
Market cap7.33M
Market cap7.33M
Price-Earnings ratio-111.00
Price-Earnings ratio-111.00
Dividend yield—
Dividend yield—
Average volume32.40K
Average volume32.40K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$25.00
52 Week high$25.00
52 Week low$9.25
52 Week low$9.25
Stock Snapshot
With a market cap of 7.33M, Larkspur Health Acquisition(LSPR) trades at $0.91. The stock has a price-to-earnings ratio of -111.00.
During the trading day, Larkspur Health Acquisition(LSPR) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 32.4K.
Over the past 52 weeks, Larkspur Health Acquisition(LSPR) stock has traded between a high of $25.00 and a low of $9.25.
Over the past 52 weeks, Larkspur Health Acquisition(LSPR) stock has traded between a high of $25.00 and a low of $9.25.
People also own
Based on the portfolios of people who own LSPR. This list is generated using Robinhood data, and it’s not a recommendation.